Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes
NCT07207304Completed
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Feb 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Lidocaine Hydrochloride Injection, without epinephrine, propofol injection (veterinary) and sevoflurane in hepatocellular carcinoma (HCC) and hepatic metastasis (4 arms), sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Primary endpoints: Overall Survival at 1 year and NETosis quantification. Started Feb 2022; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinepropofol injection (veterinary)sevoflurane
03
Conditions
hepatocellular carcinoma (HCC)hepatic metastasis
Beyond the preview
Go deeper on NCT07207304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07207304.